Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.

Cavalli LR, Riggins RB, Wang A, Clarke R, Haddad BR.

Breast Cancer Res Treat. 2010 May;121(1):227-31. doi: 10.1007/s10549-009-0509-8. Epub 2009 Aug 21.

PMID:
19697121
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Frequent loss of the BLID gene in early-onset breast cancer.

Cavalli LR, Noone AM, Makambi KH, Rone JD, Kasid UN, Haddad BR.

Cytogenet Genome Res. 2011;135(1):19-24. doi: 10.1159/000330265. Epub 2011 Aug 12.

PMID:
21846966
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.

Hawthorn L, Luce J, Stein L, Rothschild J.

BMC Cancer. 2010 Aug 27;10:460. doi: 10.1186/1471-2407-10-460.

PMID:
20799942
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.

Johannsdottir HK, Jonsson G, Johannesdottir G, Agnarsson BA, Eerola H, Arason A, Heikkila P, Egilsson V, Olsson H, Johannsson OT, Nevanlinna H, Borg A, Barkardottir RB.

Int J Cancer. 2006 Sep 1;119(5):1052-60.

PMID:
16570289
[PubMed - indexed for MEDLINE]
5.

Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.

Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ.

Breast Cancer Res. 2011;13(6):R111. doi: 10.1186/bcr3053. Epub 2011 Nov 4.

PMID:
22053985
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.

Gao X, Porter AT, Honn KV.

Adv Exp Med Biol. 1997;407:41-53. Review.

PMID:
9321930
[PubMed - indexed for MEDLINE]
7.

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG.

J Natl Cancer Inst. 2000 Apr 5;92(7):564-9.

PMID:
10749912
[PubMed - indexed for MEDLINE]
Free Article
8.

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.

Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW.

Genes Chromosomes Cancer. 1997 Mar;18(3):181-92.

PMID:
9071571
[PubMed - indexed for MEDLINE]
9.

Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer.

Charef-Hamza S, Trimeche M, Ziadi S, Amara K, Gaddas N, Mokni M, Sriha B, Yacoubi T, Korbi S.

Cancer Lett. 2005 Jun 28;224(2):185-91. Epub 2004 Dec 15.

PMID:
15914269
[PubMed - indexed for MEDLINE]
10.

Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.

Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A.

Gynecol Oncol. 2004 Dec;95(3):449-55.

PMID:
15581945
[PubMed - indexed for MEDLINE]
11.

Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.

Bièche I, Lidereau R.

Mol Carcinog. 2000 Nov;29(3):151-8.

PMID:
11108660
[PubMed - indexed for MEDLINE]
12.

Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma.

Yang Q, Yoshimura G, Nakamura M, Nakamura Y, Shan L, Suzuma T, Tamaki T, Umemura T, Mori I, Kakudo K.

Breast Cancer Res Treat. 2001 Nov;70(1):39-45.

PMID:
11767003
[PubMed - indexed for MEDLINE]
13.

Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.

Martinez A, Walker RA, Shaw JA, Dearing SJ, Maher ER, Latif F.

Mol Pathol. 2001 Oct;54(5):300-6.

PMID:
11577171
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Frequent loss of heterozygosity at chromosome 13q12-13 with BRCA2 markers in sporadic male breast cancer.

Prechtel D, Werenskiold AK, Prechtel K, Keller G, Höfler H.

Diagn Mol Pathol. 1998 Feb;7(1):57-62.

PMID:
9646036
[PubMed - indexed for MEDLINE]
15.

Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors.

Li Z, Chen B, Wu Y, Jin F, Xia Y, Liu X.

BMC Cancer. 2010 Mar 16;10:98. doi: 10.1186/1471-2407-10-98.

PMID:
20230646
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.

Rio PG, Pernin D, Bay JO, Albuisson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ, Bignon YJ.

Int J Oncol. 1998 Oct;13(4):849-53.

PMID:
9735416
[PubMed - indexed for MEDLINE]
17.

Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas.

Rhiem K, Todt U, Wappenschmidt B, Klein A, Wardelmann E, Schmutzler RK.

Anticancer Res. 2010 Sep;30(9):3445-9.

PMID:
20944121
[PubMed - indexed for MEDLINE]
18.

Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer.

Rouba A, Kaisi N, Al-Chaty E, Badin R, Pals G, Young C, Worsham MJ.

Int J Mol Med. 2000 Nov;6(5):565-9.

PMID:
11029525
[PubMed - indexed for MEDLINE]
19.

Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene.

Rio PG, Maurizis JC, Peffault de Latour M, Bignon YJ, Bernard-Gallon DJ.

Int J Cancer. 1999 Mar 15;80(6):823-6.

PMID:
10074913
[PubMed - indexed for MEDLINE]
20.

Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.

Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):539-46.

PMID:
11173152
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk